Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure allows for selective cross-coupling reactions, making it valuable in constructing complex heterocyclic systems found in bioactive molecules. Commonly employed in Suzuki-Miyaura coupling reactions to form carbon-carbon bonds during the preparation of drug candidates. The presence of the boronic acid group enables efficient and mild reaction conditions, improving yield and purity in medicinal chemistry applications.